TrialBlood2025
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial.
Matthias Stelljes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it